# ZetaRx Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zetarx-biosciences

- Industry: Biotechnology
- Headquarters: Seattle, US
- Total disclosed funding: $1.8M
- Latest round: Series B (Dec 7, 2012)
- Investors on record: 2

## About

Founded in 2009 and based in Washington, US, ZetaRx Biosciences, Inc. operates as a biotechnology company that develops immunotherapies for the treatment of cancer.

## Funding rounds

- Series B, Dec 7, 2012, $1.8M — Oxford Bioscience Partners, New England Partners

## Investors

- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series B
- New England Partners (https://capitalatlas.ai/funds/new-england-partners) — Series B